Sepsis is a life-threatening condition caused by organ dysfunction resulting from the body's dysregulated response to infection. Annually, sepsis affects more than 31 million people worldwide, with a ...

Traditional approaches for detecting Alzheimer’s disease (AD) that rely on examining the brain for amyloid plaques have limitations in accuracy and early detection. Although the industry has ...

The current standard of care for psychosis is a diagnostic interview, but what if it could be diagnosed before the first symptom emerged? Researchers are pointing toward a potential biomarker in the ...

Many Alzheimer’s experts were dismayed — but not surprised — when the Alzheimer’s Association stated that the disease could be diagnosed on the basis of pathology using biomarkers, rather than ...

A definition of Alzheimer's disease -- one that requires objective cognitive deficits in addition to brain amyloid for Alzheimer's to be diagnosed -- was proposed by the International Working Group ...

Alzheimer’s disease is a neurodegenerative condition that can cause difficulties with thinking and memory and physical decline. Biomarkers can help experts monitor its development, progression, and ...

The diagnosis of anaphylaxis can be tricky, especially in the absence of known triggers and when other conditions, such as urticaria and asthma, mimic aspects of the reaction. Biomarkers can help to ...

"If we can attack the disease before those symptoms start, we're doing a major service to the patient and to society." ...

New guidelines for blood-based biomarkers, the impact of hormone replacement therapy and risks for cognitive decline with red ...

Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor development.